Loralee B. Rupp

3.0k total citations
66 papers, 1.5k citations indexed

About

Loralee B. Rupp is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Loralee B. Rupp has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 59 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Loralee B. Rupp's work include Liver Disease Diagnosis and Treatment (56 papers), Hepatitis C virus research (53 papers) and Hepatitis B Virus Studies (31 papers). Loralee B. Rupp is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Hepatitis C virus research (53 papers) and Hepatitis B Virus Studies (31 papers). Loralee B. Rupp collaborates with scholars based in United States and Kenya. Loralee B. Rupp's co-authors include Stuart C. Gordon, Joseph A. Boscarino, Anne C. Moorman, Scott D. Holmberg, Mei Lü, Eyasu H. Teshale, Philip R. Spradling, Mark A. Schmidt, Vinutha Vijayadeva and Sheri Trudeau and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Loralee B. Rupp

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Loralee B. Rupp United States	20	1.3k	1.3k	120	78	72	66	1.5k
Nyingi Kemmer United States	20	791 0.6×	649 0.5×	390 3.3×	42 0.5×	62 0.9×	65	1.1k
Hugo Perazzo Brazil	16	586 0.5×	844 0.7×	112 0.9×	55 0.7×	24 0.3×	60	1.1k
Hamish Innes United Kingdom	21	867 0.7×	917 0.7×	30 0.3×	108 1.4×	25 0.3×	57	1.1k
Smruti R. Mohanty United States	11	235 0.2×	420 0.3×	141 1.2×	50 0.6×	105 1.5×	38	665
Peter Jarčuška Slovakia	18	432 0.3×	490 0.4×	159 1.3×	50 0.6×	22 0.3×	82	915
Mohamed Hassany Egypt	16	775 0.6×	778 0.6×	36 0.3×	36 0.5×	21 0.3×	95	1.0k
Kristin K. Snow United States	12	843 0.7×	861 0.7×	33 0.3×	26 0.3×	23 0.3×	16	1.4k
Martin Janíčko Slovakia	14	347 0.3×	391 0.3×	126 1.1×	32 0.4×	18 0.3×	60	638
Karen F. Murray United States	15	595 0.5×	678 0.5×	72 0.6×	11 0.1×	17 0.2×	38	855
Nicolás Garcı́a Spain	18	681 0.5×	551 0.4×	228 1.9×	17 0.2×	169 2.3×	45	1.1k

Countries citing papers authored by Loralee B. Rupp

Since Specialization

Citations

This map shows the geographic impact of Loralee B. Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loralee B. Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loralee B. Rupp more than expected).

Fields of papers citing papers by Loralee B. Rupp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loralee B. Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loralee B. Rupp. The network helps show where Loralee B. Rupp may publish in the future.

Co-authorship network of co-authors of Loralee B. Rupp

This figure shows the co-authorship network connecting the top 25 collaborators of Loralee B. Rupp. A scholar is included among the top collaborators of Loralee B. Rupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loralee B. Rupp. Loralee B. Rupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lü, Mei, Loralee B. Rupp, Sheri Trudeau, et al.. (2024). Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis. Advances in Therapy. 41(2). 744–758. 2 indexed citations

Gordon, Stuart C., Yueren Zhou, Talan Zhang, et al.. (2023). Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals. Journal of Viral Hepatitis. 30(6). 544–550. 5 indexed citations

Lü, Mei, Loralee B. Rupp, Sheri Trudeau, et al.. (2023). Persistent pruritus associated with worse quality of life in patients with chronic hepatitis. Liver International. 44(2). 577–588. 6 indexed citations

Wong, Robert J., Loralee B. Rupp, Mei Lü, et al.. (2023). Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United States. Journal of Viral Hepatitis. 30(6). 512–519. 1 indexed citations

González, Humberto C., Mei Lü, Yueren Zhou, et al.. (2023). Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic. Hepatology International. 17(6). 1637–1644. 1 indexed citations

Lü, Mei, Reena Salgia, Jia Li, et al.. (2023). Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. Journal of Viral Hepatitis. 30(9). 746–755. 5 indexed citations

Gordon, Stuart C., Kuan-Han Wu, Keith D. Lindor, et al.. (2020). Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. The American Journal of Gastroenterology. 115(2). 262–270. 16 indexed citations

Lü, Mei, Christopher L. Bowlus, Keith D. Lindor, et al.. (2020). <p>Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis</p>. Clinical Epidemiology. Volume 12. 1261–1267. 4 indexed citations

Abara, Winston E., Philip R. Spradling, Anne C. Moorman, et al.. (2019). Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis. Journal of Gastrointestinal Cancer. 51(2). 461–468. 6 indexed citations

10.

Lü, Mei, David L. Rabin, Loralee B. Rupp, et al.. (2017). Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records. Clinical Epidemiology. Volume 9. 369–376. 25 indexed citations

11.

Boscarino, Joseph A., Anne C. Moorman, Loralee B. Rupp, et al.. (2017). Comparison of ICD-9 Codes for Depression and Alcohol Misuse to Survey Instruments Suggests These Codes Should Be Used with Caution. Digestive Diseases and Sciences. 62(10). 2704–2712. 21 indexed citations

12.

Xing, Jian, Philip R. Spradling, Anne C. Moorman, et al.. (2017). A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C. Digestive Diseases and Sciences. 62(11). 3221–3234. 2 indexed citations

13.

Li, Jia, Talan Zhang, Stuart C. Gordon, et al.. (2017). Impact of sustained virological response on incidence of type 2 diabetes in hepatitis c patients.. 66. 2 indexed citations

14.

Moorman, Anne C., Xin Tong, Philip R. Spradling, et al.. (2016). Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS). Digestive Diseases and Sciences. 61(7). 2087–2093. 17 indexed citations

15.

Gordon, Stuart C., Lois Lamerato, Loralee B. Rupp, et al.. (2015). Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study. The American Journal of Gastroenterology. 110(8). 1169–1177. 29 indexed citations

16.

Allison, Robert D., Xin Tong, Anne C. Moorman, et al.. (2015). Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006–2010. Journal of Hepatology. 63(4). 822–828. 122 indexed citations

17.

Lü, Mei, Loralee B. Rupp, Anne C. Moorman, et al.. (2014). Comparative Effectiveness Research of Chronic Hepatitis B and C Cohort Study (CHeCS): Improving Data Collection and Cohort Identification. Digestive Diseases and Sciences. 59(12). 3053–3061. 8 indexed citations

18.

Vijayadeva, Vinutha, Anne C. Moorman, Loralee B. Rupp, et al.. (2014). Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders.. PubMed. 20(4). e98–e104. 14 indexed citations

19.

Gordon, Stuart C., Lois Lamerato, Loralee B. Rupp, et al.. (2013). Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population. Clinical Gastroenterology and Hepatology. 12(5). 885–893. 111 indexed citations

20.

Spradling, Philip R., Loralee B. Rupp, Anne C. Moorman, et al.. (2012). Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence. Clinical Infectious Diseases. 55(8). 1047–1055. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact